These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31144498)

  • 41. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
    Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
    Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis.
    Klecka J; Holubec L; Pesta M; Topolcan O; Hora M; Eret V; Finek J; Chottova-Dvorakova M; Babjuk M; Novak K; Stolz J
    Anticancer Res; 2010 Feb; 30(2):665-70. PubMed ID: 20332487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluctuation in prostate cancer gene 3 (PCA3) score in men undergoing first or repeat prostate biopsies.
    De Luca S; Passera R; Cappia S; Bollito E; Randone DF; Milillo A; Papotti M; Porpiglia F
    BJU Int; 2014 Dec; 114(6b):E56-E61. PubMed ID: 24472071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
    Xu YH; Deng JL; Wang G; Zhu YS
    Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PCA3 and PSA gene activity correlates with the true tumor cell burden in prostate cancer lymph node metastases.
    Tsaur I; Hennenlotter J; Oppermann E; Munz M; Kuehs U; Stenzl A; Schilling D
    Cancer Biomark; 2015; 15(3):311-6. PubMed ID: 25769446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
    de Kok JB; Verhaegh GW; Roelofs RW; Hessels D; Kiemeney LA; Aalders TW; Swinkels DW; Schalken JA
    Cancer Res; 2002 May; 62(9):2695-8. PubMed ID: 11980670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long Non-Coding RNAs - Current Methods of Detection and Clinical Applications.
    Moráňová L; Bartošík M
    Klin Onkol; 2019; 32(Supplementum 3):65-71. PubMed ID: 31627708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies.
    Pang KH; Rosario DJ; Morgan SL; Catto JW
    PLoS One; 2017; 12(4):e0175070. PubMed ID: 28380027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of cyclopamine on the proliferation and apoptosis of LNCaP cells and expression of the PCA3 gene in human prostate cancer].
    Lü ZY; Lü LD; Liang-Hong MA
    Zhonghua Nan Ke Xue; 2014 Mar; 20(3):213-7. PubMed ID: 24738456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathological patterns of prostate biopsy in men with fluctuations of prostate cancer gene 3 score: a preliminary report.
    De Luca S; Passera R; Cappia S; Bollito E; Randone DF; Porpiglia F
    Anticancer Res; 2015 Apr; 35(4):2417-22. PubMed ID: 25862908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative real-time RT-PCR assay for PCA3.
    Väänänen RM; Rissanen M; Kauko O; Junnila S; Väisänen V; Nurmi J; Alanen K; Nurmi M; Pettersson K
    Clin Biochem; 2008 Jan; 41(1-2):103-8. PubMed ID: 17996198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Value and Evaluability of the PCA3 Urine Assay in Prostate Carcinoma is Independent of the Tumor Localization.
    Neumann E; Hennenlotter J; Todenhöfer T; Scharpf M; Neumann T; Schilling D; Stenzl A; Bedke J
    Adv Ther; 2017 Apr; 34(4):966-974. PubMed ID: 28290096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of prostate cancer LncRNAs by RNA-Seq.
    Hu CC; Gan P; Zhang RY; Xue JX; Ran LK
    Asian Pac J Cancer Prev; 2014; 15(21):9439-44. PubMed ID: 25422238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance.
    van Poppel H; Haese A; Graefen M; de la Taille A; Irani J; de Reijke T; Remzi M; Marberger M
    BJU Int; 2012 Feb; 109(3):360-6. PubMed ID: 21883822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of nuclear internalization of Tat peptides by fluorescent dyes and receptor-avid peptides.
    Shen D; Liang K; Ye Y; Tetteh E; Achilefu S
    FEBS Lett; 2007 May; 581(9):1793-9. PubMed ID: 17416362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
    Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H
    Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.
    Zhang Y; Pitchiaya S; Cieślik M; Niknafs YS; Tien JC; Hosono Y; Iyer MK; Yazdani S; Subramaniam S; Shukla SK; Jiang X; Wang L; Liu TY; Uhl M; Gawronski AR; Qiao Y; Xiao L; Dhanasekaran SM; Juckette KM; Kunju LP; Cao X; Patel U; Batish M; Shukla GC; Paulsen MT; Ljungman M; Jiang H; Mehra R; Backofen R; Sahinalp CS; Freier SM; Watt AT; Guo S; Wei JT; Feng FY; Malik R; Chinnaiyan AM
    Nat Genet; 2018 Jun; 50(6):814-824. PubMed ID: 29808028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer.
    Stephan C; Jung K; Semjonow A; Schulze-Forster K; Cammann H; Hu X; Meyer HA; Bögemann M; Miller K; Friedersdorff F
    Clin Chem; 2013 Jan; 59(1):280-8. PubMed ID: 23213079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing blood platelets as RNA biomarker source for prostate cancer.
    Hänze J; Jakubowski P; Heers H; Hegele A; Timmesfeld N; Hofmann R; Olbert PJ
    Biomarkers; 2016 Nov; 21(7):653-9. PubMed ID: 27121394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy.
    Durand X; Xylinas E; Radulescu C; Haus-Cheymol R; Moutereau S; Ploussard G; Forgues A; Robert G; Vacherot F; Loric S; Allory Y; Ruffion A; de la Taille A
    BJU Int; 2012 Jul; 110(1):43-9. PubMed ID: 22221521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.